Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK

Molecular Biology of the Cell

Volumn 17, Issue 1, 2006, Pages 438-447

  McKinsey, Timothy A ^a   Kuwahara, Koichiro ^b   Bezprozvannaya, Svetlana ^b   Olson, Eric N ^b  

^a Myogen/Gilead Inc   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; BKCA POTASSIUM CHANNEL; HISTONE DEACETYLASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEGALIN; MYOCYTE ENHANCER FACTOR 2; POTASSIUM CHANNEL; PROTEIN ANKRA2; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN RFXANK; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CHROMATIN; CONTROLLED STUDY; GENE ACTIVATION; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANKYRINS; CELL LINE; CERCOPITHECUS AETHIOPS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 30044442933     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E05-07-0612     Document Type: Article

References (38)

1. Brickey, J. W., Felix, N. J., Griffiths, R., Zhang, J., Wang, B., Piskurich, J. F., Itoh-Lindstrom, Y., Coffman, T. M., and Ting, J. P. (2002). Prolonged survival of class II transactivator-defident cardiac allografts. Transplantation 74, 1341-1348.
2. Burd, A. L., Ingraham, R. H., Goldrick, S. E., Kroe, R. R., Crute, J. J., and Grygon, C. A. (2004). Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins. Biochemistry 43, 12750-12760.
3. Chang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J., and Olson, E. N. (2004). Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart. Mol. Cell. Biol. 24, 8467-8476.
4. Chang, S., Bezprozvannaya, S., Li, S., and Olson, E. N. (2005). An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proc. Natl. Acad. Sci. USA 102, 8120-8125.
5. Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., and Verdin, E. (2002). Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9, 45-57.
6. Grozinger, C. M., and Schreiber, S. L. (2000). Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97, 7835-7840.
7. Harrison, B. C., Roberts, C. R., Hood, D. B., Sweeney, M., Gould, J. M., Bush, E. W., and McKinsey, T. A. (2004). The CRM1 nuclear export receptor controls pathological cardiac gene expression. Mol. Cell. Biol. 24, 10636-10649.
8. Jenuwein, T., and Allis, C. D. (2001). Translating the histone code. Science 293, 1074-1080.
9. Lemercier, C., Verdel, A., Galloo, B., Curtet, S., Brocard, M. P., and Khochbin, S. (2000). mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275, 15594-15599.
10. Lim, H. H., and Park, C. S. (2005). Identification and functional characterization of ankyrin-repeat family protein ANKRA as a protein interacting with BKCa channel. Mol. Biol. Cell 16, 1013-1025.
11. Long, A. B., and Boss, J. M. (2005). Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2. Immunogenetics 56, 788-797.
12. Lu, J., McKinsey, T. A., Nicol, R. L., and Olson, E. N. (2000). Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 97, 4070-4075.
13. Masternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J. C., Hochstrasser, D. F., Mach, B., and Reith, W. (1998). A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20, 273-277.
14. McKinsey, T. A., Zhang, C. L., Lu, J., and Olson, E. N. (2000a). Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111.
15. McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2000b). Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin- dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 97, 14400-14405.
16. McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2002). MEF2, a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27, 40-47.
17. Miska, E. A., Karlsson, C., Langley, E., Nielsen, S. J., Pines, J., and Kouzarides, T. (1999). HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18, 5099-5107.
18. Mosavi, L. K., Cammett, T. J., Desrosiers, D. C., and Peng, Z. Y. (2004). The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 13, 1435-1448.
19. Nagarajan, U. M., Louis-Plence, P., DeSandro, A., Nilsen, R., Bushey, A., and Boss, J. M. (1999). RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10, 153-162.
20. Nagy, L., Kao, H. Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Aver, D. E., Schreiber, S. L., and Evans, R. M. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380.
21. Nekrep, N., Fontes, J. D., Geyer, M., and Peterlin, B. M. (2003). When the lymphocyte loses its clothes. Immunity 18, 453-457.
22. Parra, M., Kasler, H., McKinsey, T. A., Olson, E. N., and Verdin, E. (2005). Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J. Biol. Chem. 280, 13762-13770.
23. Rader, K., Orlando, R. A., Lou, X., and Farquhar, M. G. (2000). Characterization of ANKRA, a novel ankyrin repeat protein that interacts with the cytoplasmic domain of megalin J. Am. Soc. Nephrol. 11, 2167-2178.
24. Reith, W., and Mach, B. (2001). The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19, 331-373.
25. Singh, G., Singh, B., Trajkovic, V., and Sharma, P. (2005). Mycobacterium tuberculosis 6kDa early secreted antigenic target stimulates activation of J774 macrophages. Immunol. Lett. 98, 180-188.
26. Sparrow, D. B., Miska, E. A., Langley, E., Reynaud-Deonauth, S., Kotecha, S., Towers, N., Spohr, G., Kouzarides, T., and Mohun, T. J. (1999). MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 18, 5085-5098.
27. Swanberg, M. et al. (2005). MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet. 37, 486-494.
28. Vega, R. B. et al. (2004a). Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555-566.
29. Vega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., and McKinsey, T. A. (2004b). Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell. Biol. 24, 8374-8385.
30. Verdin, E., Dequiedt, F., and Kasler, H. G. (2003). Class II histone deacetylases: versatile regulators. Trends Genet. 19, 286-293.
31. Wang, A. H., Bertos, N. R., Vezmar, M., Pelletier, N., Crosato, M., Heng, H. H., Thing, J. P., Han, J., and Yang, X. J. (1999). HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19, 7816-7827.
32. Wang, A. H., Kruhlak, M. J., Wu, J., Bertos, N. R., Vezmar, M., Posner, B. J., Bazett-Jones, D. P., and Yang, X. J. (2000). Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell Biol. 20, 6904-6912.
33. Wang, A. H., Gregoire, S., Zika, E., Xiao, L., Li, C. S., Li, H., Wright, K. L., Th'ng, J., and Yang, X. J. (2005). Identification of the ankyrin-repeat proteins ANKRA and RFXANK as novel partners of class IIA histone deacetylases. J. Biol. Chem. 280, 29117-29127.
34. Yang, X.-J., and Gregoire, S. (2005). Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol. Cell. Biol. 25, 2873-2884.
35. Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., and Olson, E. N. (2002). Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488.
36. Zhu, X. S., Linhoff, M. W., Li, G., Chin, K. C., Maity, S. N., and Ting, J. P. (2000). Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell. Biol. 20, 6051-6061.
37. Zika, E., Greer, S. F., Zhu, X. S., and Ting, J. P. (2003). Historic deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Mol. Cell Biol. 23, 3091-3102.
38. Zika, E., and Ting, J. P. (2005). Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr. Opin. Immunol. 17, 58-64.